(Q45300839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Antonio L Teixeira

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Arthur Kummer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Izabela Guimarães Barbosa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Biomarkers in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

871-887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21133708%20AND%20SRC:MED&resulttype=core&format=json

Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neurotrophins and their receptors: a convergence point for many signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Regulation of cell survival by secreted proneurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Activation of p75NTR by proBDNF facilitates hippocampal long-term depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Requirement for BDNF in activity-dependent survival of cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Biological characterization and optical imaging of brain-derived neurotrophic factor-green fluorescent protein suggest an activity-dependent local release of brain-derived neurotrophic factor in neurites of cultured hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Mice lacking brain-derived neurotrophic factor develop with sensory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Learning deficit in BDNF mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neurogenesis inhibition in the dorsal vagal complex by chronic immobilization stress in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Role of neurotrophic factors in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Physiology of BDNF: focus on hypothalamic function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

TrkB signalling pathways in LTP and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Oligomers of beta-amyloid peptide inhibit BDNF-induced arc expression in cultured cortical Neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF is essential to promote persistence of long-term memory storage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neurotrophin-regulated signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The yin and yang of neurotrophin action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF plasma levels in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Peripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The genetics of depression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor serum levels before and after treatment for acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Whole blood BDNF levels in healthy twins discordant for affective disorder: Association to life events and neuroticism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Allostatic load in bipolar disorder: implications for pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Depression gets old fast: do stress and depression accelerate cell aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

New insights into brain BDNF function in normal aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The immediate early gene arc/arg3.1: regulation, mechanisms, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor is reduced in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF modulates normal human hippocampal ageing [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain volumes and Val66Met polymorphism of the BDNF gene: local or global effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neuropathologic features of amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Voxel-based morphometry in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Stage-dependent BDNF serum concentrations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neuropathology and the neuroinflammation idea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The Alzheimer's disease mitochondrial cascade hypothesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Adult neurogenesis is functionally associated with AD-like neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum levels of brain-derived neurotrophic factor in Sydenham's chorea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Overexpression of alpha-synuclein down-regulates BDNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Striatal dopamine output is compromised within +/- BDNF mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Differential loss of striatal projection neurons in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Brain-derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Endurance training enhances BDNF release from the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Effects of aerobic exercise on mild cognitive impairment: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Recreational physical activity and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The exercise-induced expression of BDNF within the hippocampus varies across life-span

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

The role of neurotrophins in inflammation and allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.111